本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tenaya Therapeutics Inc

0.6338
+0.093817.37%
盘后0.6301-0.0037-0.58%19:57 EDT
成交量:398.03万
成交额:239.95万
市值:1.03亿
市盈率:-0.55
高:0.6349
开:0.5600
低:0.5500
收:0.5400
数据加载中...
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/25

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]